201 related articles for article (PubMed ID: 20549133)
1. Levosimendan in acute decompensated heart failure: systematic review and meta-analysis.
Ribeiro RA; Rohde LE; Polanczyk CA
Arq Bras Cardiol; 2010 Aug; 95(2):230-7. PubMed ID: 20549133
[TBL] [Abstract][Full Text] [Related]
2. Levosimendan Treatment for Heart Failure: A Systematic Review and Meta-Analysis.
Gong B; Li Z; Yat Wong PC
J Cardiothorac Vasc Anesth; 2015 Dec; 29(6):1415-25. PubMed ID: 26275522
[TBL] [Abstract][Full Text] [Related]
3. Levosimendan versus dobutamine in critically ill patients: a meta-analysis of randomized controlled trials.
Huang X; Lei S; Zhu MF; Jiang RL; Huang LQ; Xia GL; Zhi YH
J Zhejiang Univ Sci B; 2013 May; 14(5):400-15. PubMed ID: 23645177
[TBL] [Abstract][Full Text] [Related]
4. Effects of levosimendan on mortality and hospitalization. A meta-analysis of randomized controlled studies.
Landoni G; Biondi-Zoccai G; Greco M; Greco T; Bignami E; Morelli A; Guarracino F; Zangrillo A
Crit Care Med; 2012 Feb; 40(2):634-46. PubMed ID: 21963578
[TBL] [Abstract][Full Text] [Related]
5. Levosimendan: a calcium-sensitizing agent for the treatment of patients with decompensated heart failure.
Lehtonen L
Curr Heart Fail Rep; 2004 Sep; 1(3):136-44. PubMed ID: 16036037
[TBL] [Abstract][Full Text] [Related]
6. Levosimendan for the treatment of acute severe heart failure: a meta-analysis of randomised controlled trials.
Delaney A; Bradford C; McCaffrey J; Bagshaw SM; Lee R
Int J Cardiol; 2010 Feb; 138(3):281-9. PubMed ID: 18817994
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of levosimendan in patients with acute right heart failure: A meta-analysis.
Qiu J; Jia L; Hao Y; Huang S; Ma Y; Li X; Wang M; Mao Y
Life Sci; 2017 Sep; 184():30-36. PubMed ID: 28689804
[TBL] [Abstract][Full Text] [Related]
8. Safety and efficacy of a novel calcium sensitizer, levosimendan, in patients with left ventricular failure due to an acute myocardial infarction. A randomized, placebo-controlled, double-blind study (RUSSLAN).
Moiseyev VS; Põder P; Andrejevs N; Ruda MY; Golikov AP; Lazebnik LB; Kobalava ZD; Lehtonen LA; Laine T; Nieminen MS; Lie KI;
Eur Heart J; 2002 Sep; 23(18):1422-32. PubMed ID: 12208222
[TBL] [Abstract][Full Text] [Related]
9. Levosimendan in patients with low-output heart failure: lessons from the LIDO trial.
Follath F
Ital Heart J; 2003 May; 4 Suppl 2():34S-38S. PubMed ID: 14635368
[TBL] [Abstract][Full Text] [Related]
10. Levosimendan: a review of its use in the management of acute decompensated heart failure.
Innes CA; Wagstaff AJ
Drugs; 2003; 63(23):2651-71. PubMed ID: 14636085
[TBL] [Abstract][Full Text] [Related]
11. [Levosimendan in cardiology and intensive care medicine].
Delle Karth G; Heinz G
Wien Klin Wochenschr; 2004 Jan; 116(1-2):6-14. PubMed ID: 15030117
[TBL] [Abstract][Full Text] [Related]
12. Intravenous levosimendan treatment is cost-effective compared with dobutamine in severe low-output heart failure: an analysis based on the international LIDO trial.
Cleland JG; Takala A; Apajasalo M; Zethraeus N; Kobelt G
Eur J Heart Fail; 2003 Jan; 5(1):101-8. PubMed ID: 12559222
[TBL] [Abstract][Full Text] [Related]
13. Effects of Levosimendan on Patients with Heart Failure Complicating Acute Coronary Syndrome: A Meta-Analysis of Randomized Controlled Trials.
Shang G; Yang X; Song D; Ti Y; Shang Y; Wang Z; Tang M; Zhang Y; Zhang W; Zhong M
Am J Cardiovasc Drugs; 2017 Dec; 17(6):453-463. PubMed ID: 28597399
[TBL] [Abstract][Full Text] [Related]
14. Inotropic agents and vasodilator strategies for acute myocardial infarction complicated by cardiogenic shock or low cardiac output syndrome.
Unverzagt S; Wachsmuth L; Hirsch K; Thiele H; Buerke M; Haerting J; Werdan K; Prondzinsky R
Cochrane Database Syst Rev; 2014 Jan; (1):CD009669. PubMed ID: 24385385
[TBL] [Abstract][Full Text] [Related]
15. Levosimendan: a novel inotropic agent for treatment of acute, decompensated heart failure.
Earl GL; Fitzpatrick JT
Ann Pharmacother; 2005 Nov; 39(11):1888-96. PubMed ID: 16219899
[TBL] [Abstract][Full Text] [Related]
16. Is levosimendan effective in paediatric heart failure and post-cardiac surgeries?
Angadi U; Westrope C; Chowdhry MF
Interact Cardiovasc Thorac Surg; 2013 Oct; 17(4):710-4. PubMed ID: 23832921
[TBL] [Abstract][Full Text] [Related]
17. Levosimendan vs dobutamine for patients with acute decompensated heart failure: the SURVIVE Randomized Trial.
Mebazaa A; Nieminen MS; Packer M; Cohen-Solal A; Kleber FX; Pocock SJ; Thakkar R; Padley RJ; Põder P; Kivikko M;
JAMA; 2007 May; 297(17):1883-91. PubMed ID: 17473298
[TBL] [Abstract][Full Text] [Related]
18. Levosimendan: a new era for inodilator therapy for heart failure?
Cleland JG; McGowan J
Curr Opin Cardiol; 2002 May; 17(3):257-65. PubMed ID: 12015475
[TBL] [Abstract][Full Text] [Related]
19. Levosimendan: beyond its simple inotropic effect in heart failure.
Antoniades C; Tousoulis D; Koumallos N; Marinou K; Stefanadis C
Pharmacol Ther; 2007 May; 114(2):184-97. PubMed ID: 17363065
[TBL] [Abstract][Full Text] [Related]
20. Levosimendan in decompensated heart failure patients: efficacy in a Brazilian cohort. Results of the BELIEF study.
Bocchi EA; Vilas-Boas F; Moreira Mda C; Barretto AC; Lage S; Albuquerque D; Baima J; Rassi S; Ribeiro JP; ;
Arq Bras Cardiol; 2008 Mar; 90(3):182-90. PubMed ID: 18392398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]